BRCA1/2-stratified immune profiling of treatment-naive high-grade serous ovarian cancer ascites identifies a Treg-enriched ascitic immune phenotype.

Sharma M, Kaur B, Rai B, Sachdeva MUS, Sharma AR, Gupta P, Gautam U, Bagga R, Srinivasan R

DOI: 10.4132/jptm.2026.07.27
Published: 2026 Sep
Container: Journal of pathology and translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4132/jptm.2026.07.27,
  title = {BRCA1/2-stratified immune profiling of treatment-naive high-grade serous ovarian cancer ascites identifies a Treg-enriched ascitic immune phenotype.},
  author = {Sharma M and Kaur B and Rai B and Sachdeva MUS and Sharma AR and Gupta P and Gautam U and Bagga R and Srinivasan R},
  year = {2026},
  journal = {Journal of pathology and translational medicine},
  doi = {10.4132/jptm.2026.07.27},
  url = {https://doi.org/10.4132/jptm.2026.07.27}
}

RIS

TY  - JOUR
TI  - BRCA1/2-stratified immune profiling of treatment-naive high-grade serous ovarian cancer ascites identifies a Treg-enriched ascitic immune phenotype.
AU  - Sharma M
AU  - Kaur B
AU  - Rai B
AU  - Sachdeva MUS
AU  - Sharma AR
AU  - Gupta P
AU  - Gautam U
AU  - Bagga R
AU  - Srinivasan R
PY  - 2026
JO  - Journal of pathology and translational medicine
DO  - 10.4132/jptm.2026.07.27
UR  - https://doi.org/10.4132/jptm.2026.07.27
ER  -

APA

M, S., B, K., B, R., MUS, S., AR, S., P, G., U, G., R, B., & R, S. (2026). BRCA1/2-stratified immune profiling of treatment-naive high-grade serous ovarian cancer ascites identifies a Treg-enriched ascitic immune phenotype.. Journal of pathology and translational medicine. https://doi.org/10.4132/jptm.2026.07.27

Source records

pubmed · retrieved 2026-09-27T07:00:31.500Z